ChemSpider 2D Image | UQ0600000 | C19H26NaO9P

UQ0600000

  • Molecular FormulaC19H26NaO9P
  • Average mass452.368 Da
  • Monoisotopic mass452.121216 Da
  • ChemSpider ID4572672

  • Charge - Charge

    Double-bond stereo - Double-bond stereo

    defined stereocentres - 4 of 4 defined stereocentres

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

2H-Pyran-2-one, 5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraen-1-yl]-, sodium salt, (6R)- (1:1) [ACD/Index Name]
Fostriecin (sodium salt)
fostriecin sodium
Hydrogénophosphate de sodium et de (1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-méthyl-1-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]-1,7,9,11-tridécatétraén-4-yle [French] [ACD/IUPAC Name]
MFCD09971059
Natrium-(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-1-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]-1,7,9,11-tridecatetraen-4-ylhydrogenphosphat [German] [ACD/IUPAC Name]
Sodium (1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-1-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]-1,7,9,11-tridecatetraen-4-yl hydrogen phosphate [ACD/IUPAC Name]
UQ0600000
(6R)-5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraen-1-yl]-2H-pyran-2-one, monosodium salt
[87860-39-7] [RN]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

8TXS63IX8M [DBID]
CI-920 [DBID]
F4425_SIGMA [DBID]
NSC339638 [DBID]
NSC-339638 [DBID]
PD-110161 [DBID]
UNII:8TXS63IX8M [DBID]
UNII-8TXS63IX8M [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      Enzymes Tocris Bioscience 1840
      Originally identified as an antitumor antibiotic from Streptomyces pulveraceous. Displays potent inhibition of protein phosphatase types 2A (PP2A) and 4 (PP4) with IC50 values of 1.5 nM and 3 nM respe ctively. Also exhibits weaker inhibition of topoisomerase II (IC50 = 40 ?M) and protein phosphatase type 1 (PP1) (IC50 = 131 ?M) with no apparent inhibition of protein phosphatase type 2B (PP2B). Acti ve in vivo. Tocris Bioscience 1840
      Phosphatases Tocris Bioscience 1840
      Potent inhibitor of protein phosphatase types 2A (PP2A) and 4 (PP4) with IC50 values of 1.5 nM and 3 nM respectively. Also exhibits weaker inhibition of topoisomerase II (IC50 = 40 ?M) and protein phosphatase type 1 (PP1) (IC50 = 131 ?M) with no apparent inhibition of protein phosphatase type 2B (PP2B). Active in vivo. Originally identified as an antitumor antibiotic from Streptomyces pulveraceous. Tocris Bioscience 1840
      Potent inhibitor of protein phosphatase types 2A (PP2A) and 4 (PP4) with IC50 values of 1.5 nM and 3 nM respectively. Also exhibits weaker inhibition of topoisomerase II (IC50 = 40 muM) and protein phosphatase type 1 (PP1) (IC50 = 131 muM) with no apparent inhibition of protein phosphatase type 2B (PP2B). Active in vivo. Originally identified as an antitumor antibiotic from Streptomyces pulveraceous. Tocris Bioscience 1840
      Potent PP2A and PP4 inhibitor Tocris Bioscience 1840
      Protein Ser/Thr Phosphatases Tocris Bioscience 1840

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement